Abbott Laboratories has witnessed active trading and investor interest. It has seen shares sold and purchased by Retirement Systems of Alabama and Tidal Investments respectively. It is a key player among dividend kings, attractive for its safe dividend growth. The majority of the company's shares are held by institutional shareholders, accounting for 78% ownership. Franklin Resources and Teachers Retirement System of The State of Kentucky have significant positions in Abbott. The company insiders have also offloaded stocks worth $3.0 million. Abbott's stock performance has been strong compared to its competitors. The company has increased its dividend for 53 consecutive years and its growth in diabetes care is noteworthy. It is considered a potentially high-reward investment, with good organic growth and margin expansion and skyrocketing returns. However, investors are warned to exercise caution as the company's insiders have sold off shares. Potential growth sectors for Abbott include AI health and diabetes care. It outperformed expectations in Q3 with strong device sales, subsequently raising its full-year guidance.
Abbott Laboratories ABT News Analytics from Thu, 20 Jun 2024 07:00:00 GMT to Sat, 14 Dec 2024 12:11:59 GMT -
Rating 7
- Innovation 6
- Information 8
- Rumor -2
